The invention here relates to a product comprised of a cell line or lines intended for use as an allogeneic immunotherapy agent for the treatment of cancer in mammals and humans. All of the studies of cell-based cancer vaccines to date have one feature in common, namely the intention to ...
The goal of prostate cancer treatment isn't just to remove the cancer but to preserve the patient's quality of life. Specialized centers like the 'Changzheng Urology Pelvic Center' in Shanghai are dedicated to comprehensive post-operative care, focusing on urinary control and sexual function. Thi...
The addition of Zytiga to androgen-deprivation therapy can "significantly" increase overall survival in men with newly diagnosed, metastatic, castration-sensitive prostate cancer, concluded the STAMPEDE trial team funded by the Cancer Research UK. The findings were presented at the 2017 ASCO Annual Mee...
LHRH agonists have also been used prior to or following various local treatments in patients with clinically localised prostate cancer and at high risk for disease recurrence [5]. Thus indications for the treatment with LHRH agonists include, besides T3 metastatic prostate cancer, patients with rising...
Prostate cancer is the second leading cause of cancer-related deaths among men in the United States with a five-year relative survival rate of near 100 percent when diagnosed early. Metastatic prostate cancer has a five-year survival rate of 30 percent. Current therapeutics like first- and next...
cancer (GLOBOCAN). There was over four times the incidence of prostate cancer in 2017 as in the 1950s, but at the same time, the treatments have been improving, so many more live longer, and die with, rather than of, prostate cancer. Nevertheless, more effective treatments are urgently ...
New treatments for localized tumours—what matters first?doi:10.1038/nrurol.2012.133B. GuillonneauNature Reviews Urology
New therapeutic concepts in prostate cancer. BJU Int 2001;88(Suppl 2):43-48; discussion 49-50.Hamdy FC, Thomas BG. New therapeutic concepts in prostate cancer. BJU Int 2001;88:43-50.Hamdy FC, Thomas BG. New therapeutic concepts in prostate cancer. BJU Int 2001;88(Suppl. 2):43e8....
The invention here relates to a product comprised of a cell line or lines intended for use as an allogeneic immunotherapy agent for the treatment of cancer in mammals and humans. All of the studies of cell-based cancer vaccines to date have one feature in common, namely the intention to use...
Researchers at the University of Adelaide are spearheading a new direction in prostate cancer research, with the potential for new treatments of the disease.